Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s What Happened

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $15.40, but opened at $14.5595. Ono Pharmaceutical shares last traded at $14.5595, with a volume of 7,522 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research raised Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, the company has an average rating of “Strong Buy”.

Ono Pharmaceutical Price Performance

The stock has a 50-day moving average price of $14.71 and a 200 day moving average price of $14.82. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.28 and a quick ratio of 2.56. The firm has a market cap of $7.75 billion, a price-to-earnings ratio of 15.71 and a beta of 0.33.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.